Go or no go? Oncology decisions ahead for the FDA

Go or no go? Oncology decisions ahead for the FDA

Source: 
EP Vantage
snippet: 

The US regulator will provide verdicts on cancer projects from TG and Athenex, while Sarepta aims for its third Duchenne approval.